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Previewsunderscore the importance of identifying
genetic polymorphisms that impact au-
tophagy, as these could influence the
response to PZA/INH and the overall clin-
ical outcome. This report also highlights
the need for rapid and precise resistance
genotyping of Mtb isolates in the field.
While it is not clear if each antibiotic can
boost autophagy responses, it would be
ideal to utilize the most bactericidal
combination to engage the autophagy
pathway, as bacteriostatic agents were
not found to boost autophagy in similar
assays.
Infection with Mtb is well known to elicit
a potent inflammatory cytokine response
that is largely responsible for the disease
pathology. Evidence from several groups
has identified that cytokine production
can in part be regulated by autophagy.
In the current study, treatment of Mtb-in-
fected cells with INH reduced the produc-
tion of inflammatory cytokines TNF-a,
IL-6, and IL-1b. Furthermore, blocking
autophagy induction in Mtb-infected cells
treated with INH resulted in enhanced
inflammatory cytokine production. From
these data, one can speculate that bacte-
rial killing by autophagy and inflammatory
cytokine production are tightly coupled420 Cell Host & Microbe 11, May 17, 2012 ª2such that as bacteria are destroyed,
the need for inflammatory cytokines is
reduced. Since inflammatory cytokines
are themselves autophagy inducers, the
data presented by Kim et al. (2012)
persuasively suggest how autophagic
killing and cytokine production could
regulate each other to achieve a balance
that bolsters host defense and limits cyto-
kine-induced pathology. It is also inter-
esting to consider that exuberant cytokine
production during Mtb treatment may
itself be diagnostic of a weak autophagy
response and poor long-term prognosis.
Additional studies will be necessary to
examine this correlation as the potential
to be a valuable clinical tool.
As we can continue to mine for new
antibiotics that can treat Mtb infection,
we should keep in mind that medicines
that are decades old have been exploiting
a newly appreciated cellular defense
mechanism. Clearly, an ideal antibiotic
would target a bacterial Achilles’ heel
but also enhance the activity of endoge-
nous cellular defenses such as autoph-
agy. It may also be possible to combine
antibiotics with agents that act specifi-
cally on the host autophagy pathway to
produce combination therapies. Large-012 Elsevier Inc.scale chemical screens have begun to
identify mammalian target of rapamycin
(mTOR)-independent agents that may
serve this purpose and avoid the immuno-
suppressive effects of rapamycin or
similar agents. The current work demon-
strates that focusing therapy on both the
host and the pathogen would be an ideal
combination to strive for in the future.
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Mitochondria are dynamic organelles with many functions. In this issue of Cell Host & Microbe, Kramer and
Enquist (2012) show that mitochondrial motility and morphology are disrupted during alphaherpesvirus
infection, which aids viral replication and transport in neurons.Mitochondria have many functions in in-
fected and noninfected cells, including
energy generation, calcium homeostasis,
innate immune signaling, and apoptosis.
Disruption of mitochondrial function may
help also drive neurodegeneration and
contribute to Alzheimer’s disease, Parkin-
son’s disease, and amyotrophic lateralsclerosis (ALS) (Detmer and Chan, 2007).
Mitochondria are dynamic organelles,
and their movement is mediated by
microtubules and dynein/kinesin motor
systems. Alphaherpesviruses encode
proteins that alter mitochondrial localiza-
tion and function, primarily to reduce
apoptosis (Pomeranz et al., 2005). How-ever, the mechanisms underlying virus-
mediated alteration of mitochondrial
dynamics are unclear, particularly in
neurons.
Neurons are unique cells due to their
electrical activity and length, which re-
quires long-distance transport of car-
goes including organelles and viruses.
Cell Host & Microbe
PreviewsNeurotropic viruses including herpesvi-
ruses, rabies virus, and poliovirus use
the cellular transport machinery to move
long distances in neurons. However, the
effect of virus infection on transport of
neural cargoes, including mitochondria,
is unknown.
In this issue of Cell Host & Microbe,
Kramer and Enquist report the first study
of mitochondrial dynamics in alphaher-
pesvirus-infected neurons (Kramer and
Enquist, 2012). They found that pseudora-
bies virus (PRV) or herpes simplex virus 1
infection of primary rodent neurons re-
duced mitochondrial motility and altered
mitochondrial morphology, without major
damage to the organelles. Importantly,
disruption of mitochondrial transport
was required for efficient PRV replication
and transport in neurons.
The mechanism underlying reduced
mitochondrial motility in infected neurons
involves a unique feature of PRV infection:
the generation of pores that electrically
couple neurons independent of synaptic
transmission (McCarthy et al., 2009). The
viral envelope protein gB creates fusion
pores that link the membranes of previ-
ously independent neurons, increasing
spontaneous electrical activity. In effect,
the pores create neural ‘‘syncytia,’’ and
the resulting enhancement in action
potential firing increases cytoplasmic
calcium concentrations. The level of intra-
cellular calcium is one of the factors
known to regulate mitochondrial motion
(Macaskill et al., 2009; Saotome et al.,
2008; Wang and Schwarz, 2009). The
mitochondrial outer membrane protein
Miro senses high calcium through its
‘‘hand’’ domains (Fransson et al., 2003).
This releases the Miro-mediated tether
between mitochondria and kinesin, thus
reducing microtubule-mediated mito-
chondrial movement. Kramer and Enquist
found that PRV infection decreased levels
of kinesin-1 heavy chain associated with
mitochondria without detectable changes
to levels of the microtubule motor protein
dynein. The authors unveiled the mecha-nism of PRV-mediated mitochondrial
transport defect with an elegant combina-
tion of experiments using mutant viruses
lacking gB, a drug that enhances mito-
chondrial motility, a calcium chelator, a
calcium channel blocker, and viruses ex-
pressing a version of Miro that is unable
to sense calcium (Kramer and Enquist,
2012). Overall, this study may provide an
explanation for part of the neural damage
observed to be associated with alphaher-
pesvirus infections.
This work raises several interesting
and important questions worthy of future
investigation. First, while the calcium-
dependent Miro-based mechanism of
reduced mitochondrial transport is likely
specific for mitochondrial movement, is
transport of other organelles altered
during alphaherpesvirus infection? One
can imagine that increased cytoplasmic
calcium induced by PRV infection has
broad consequences for many organ-
elles. Second, are additional viral and/or
cellular factors involved in limiting mito-
chondrial transport? The authors point
out that reduced mitochondrial transport
occurs before the virus-induced action
potential firing and enhanced calcium
begin. Therefore, other viral and/or cel-
lular factors may contribute to limited
mitochondrial movement, particularly
early in infection. Third, do similar alter-
ations in mitochondrial motility and mor-
phology occur in vivo, and what are the
long-term consequences in animals? This
study demonstrates that PRV infection
reduces mitochondrial motility for a rela-
tively long time period (72 hr) in primary
neurons. How would this process affect
animals during infection? Does it con-
tribute to neurodegeneration later in life?
Fourth, do viruses in other families impact
mitochondrial dynamics in neurons or
other cell types? Several viral families
contain members that are neurotropic.
Are the effects on mitochondrial dyn-
amics specific to alphaherpesviruses?
Finally, the virus-mediated reduction in
mitochondrial motility promotes PRVCell Host & Microbereplication and transport, but is this effect
direct or indirect? Is mitochondrial motility
directly targeted by PRV, or is it a side
effect of increased calcium concen-
trations? How does reduced mito-
chondrial motility benefit alphaherpesvi-
ruses? Since alphaherpesviruses rely on
kinesin for transport, it is possible that
they benefit from the increased pool of
available kinesin generated by mitochon-
drial release. Another possibility is that
viruses benefit from mitochondria trap-
ped in certain cellular locations, for
location-specific energy production or
sequestration of apoptotic machinery.
Examining the specificity of mitochondrial
effects with other viral systems may help
answer these questions.ACKNOWLEDGMENTS
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